Ethyl chloroformate → (2-Phenyl-7-pyridin-4yl-[1,2,4]triazolo[1,5-a]pyridin-5-yl)-carbamic acid ethyl ester
Reaction equation
[C:1]1([C:7]2[N:22]=[C:10]3[CH:11]=[C:12]([C:16]4[CH:21]=[CH:20][N:19]=[CH:18][CH:17]=4)[CH:13]=[C:14]([NH2:15])[N:9]3[N:8]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.Cl[C:24]([O:26][CH2:27][CH3:28])=[O:25]>>[CH2:27]([O:26][C:24](=[O:25])[NH:15][C:14]1[N:9]2[N:8]=[C:7]([C:1]3[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=3)[N:22]=[C:10]2[CH:11]=[C:12]([C:16]2[CH:21]=[CH:20][N:19]=[CH:18][CH:17]=2)[CH:13]=1)[CH3:28]Participants
3
Procedure
The title compound, MS m/e (%): 360 (M+H+, 100), was prepared in accordance with the general method of example 27 from 2-phenyl-7-pyridin-4-yl-[1,2,4]triazolo[1,5-a]pyridin-5-ylamine and ethyl chloroformate.
Sources & evidence
- ORD record
- ord-0ba55956f13448f2b1aabf138db8a8ea
- Source dataset
- uspto-grants-2002_03
- Patent number
- US06355653B1
Reaction notes
Loading…